SOURCES SOUGHT
76 -- Comprehensive Electronic Scientific Journals - Draft Statement of Work
- Notice Date
- 11/2/2012
- Notice Type
- Sources Sought
- NAICS
- 511199
— All Other Publishers
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- FDA-ss-13-1110971
- Archive Date
- 11/24/2012
- Point of Contact
- Brendan McCarthy, Phone: 301-827-4680, Kyle Smith, Phone: 301-827-6774
- E-Mail Address
-
Brendan.McCarthy@fda.hhs.gov, Kyle.Smith@fda.hhs.gov
(Brendan.McCarthy@fda.hhs.gov, Kyle.Smith@fda.hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- Support Matrix Draft Statement of Work Food and Drug Administration Request for Information Comprehensive Electronic Journals Contract Type: Firm Fixed Price Notice to Small Businesses The purpose of this Sources Sought Notice is to seek declarations of technical capabilities and various information, data, and materials from all qualified vendors with special emphasis on small business concerns [including Small Businesses, SBA Certified 8(a) Small Businesses, Woman-owned Small Businesses (WOSB), Historically Underutilized Business Zone (HUBZone), and Service-Disabled Veteran-owned Small Businesses (SDVOSB)]. Food and Drug Administration intends to provide maximum practicable opportunities in its acquisitions to small business, service-disabled veteran-owned small business, HUBZone small business, SBA certified 8(a) small business. Background This Sources Sought Request for Information (RFI) is for information, planning and market research purposes only and shall not be construed as either a solicitation or obligation on the part of the Food and Drug Administration or its Centers. The purpose of this RFI is to help the FDA understand the industry best practices and technical solutions capable of providing the full range of products and/or services described in this RFI and the draft SOW. FDA will use this market research information to assess the market's capability to successfully meet the FDA's requirement. FDA welcomes responses from all interested businesses. FDA does not intend to make a selection decision or award a contract on the basis of responses nor otherwise pay for the preparation of any information submitted or FDA's use of such information. Acknowledgment of receipt of responses will not be made, nor will respondents be notified of the outcome of the FDA's review of the information received. Additionally, the FDA does not intend to hold discussions concerning this RFI with any interested parties. However, FDA reserves the right to contact vendors if additional information is required. General Instructions Responses to the RFI should not exceed 10 pages in length. The 10 page limit excludes the completed version of the "Support Matrix." They should be submitted via email to Brendan McCarthy at Brendan.mccarthy@fda.hhs.gov by 1pm Eastern on November 9, 2012. A complete response to the RFI should include answers to all of the questions below and a completed version of the attached "Support Matrix". Please note that a respondent's failure to provide a complete response to a question or fully complete the "Support Matrix" will be interpreted to mean that it does not understand the question and/or does not demonstrate the capability to provide the services required. If a vendor can only provide a portion of the total requirement, the offer will be deemed unacceptable. Responses should demonstrate the capability to provide all of the required resources. Questions: 1.The Draft SOW and the "Support Matrix" lists the topics the FDA must have online web access to. The list of topics is intended to provide an overall understanding of the breadth and sophistication the online journal must have in order to meet the needs of the FDA. Please demonstrate your capability to provide the FDA with 24/7 online access to the following areas by completing the "Support Matrix" in its entirety. If an offeror can only provide a portion of the total requirement, the offer will be deemed unacceptable. 2.If you identified any topics included in the draft SOW and "Support Matrix" that you are unable to provide, please state that fact and if necessary, describe any relevant titles or information that your company provides that you feel would be comparable to the requested topic. The comparable solution will be reviewed by the FDA to ensure it meets the standards required (see section 2.0 in draft SOW for specifics). 3.The Independent Government Cost Estimate (IGCE) for this requirement is not yet finalized; however, it is estimated that the period of performance will consist of one, 12-month base period and between two and four, 12-month optional periods. Additionally, this requirement will provide service to the entire agency. 4.Have you provided and supported the required topics to the FDA in the past? If so, please describe. To answer this question please utilize the attached document- "Support Matrix" 5.Please provide documentation of the size of your business. If you are classified as a small business, Historically Underutilized Business Zone small business, Service Disabled Veteran Owned Small Business, Woman-Owned Small Business and/or SBA 8(a) certified small business. Please provide a capability statement in addition to the other information for acquisition strategy determination. Additionally; if applicable, please demonstrate your firm's capability to meet the requirements of FAR 52.219-14, Limitations on Subcontracting. 6.Please provide suggested appropriate North American Industry Classification System (NAICS) code and rationale. 7.Please provide the following: a.Organization name b.DUNS number c.Organization's website d.Contact Name e.Contact Telephone f.Contact E-mail address g.Size designation h.Number of employees in your organization i.Your organization's current and gross revenue 8.Provide information concerning contract vehicles available to be used by the FDA in acquiring the products/services outlined in the draft SOW (GSA Federal Schedules, Government wide Acquisition Contract, etc.). Attachments: 1.Draft SOW 2.Support Matrix
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA-ss-13-1110971/listing.html)
- Place of Performance
- Address: U.S. FDA - White Oak Campus, Silver Spring, Maryland, 20993, United States
- Zip Code: 20993
- Zip Code: 20993
- Record
- SN02923951-W 20121104/121102234252-909a09fc7d0e28622ea16b35c8c62015 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |